NDC 11673-032

Fexofenadine HCl and Pseudoephedrine HCI

Fexofenadine Hcl And Pseudoephedrine Hci

Fexofenadine HCl and Pseudoephedrine HCI is a Oral Tablet, Extended Release in the Human Otc Drug category. It is labeled and distributed by Target Brands Inc.. The primary component is Fexofenadine Hydrochloride; Pseudoephedrine Hydrochloride.

Product ID11673-032_dfc91b7a-ba7d-32f7-8ade-15541094d5ae
NDC11673-032
Product TypeHuman Otc Drug
Proprietary NameFexofenadine HCl and Pseudoephedrine HCI
Generic NameFexofenadine Hcl And Pseudoephedrine Hci
Dosage FormTablet, Extended Release
Route of AdministrationORAL
Marketing Start Date2015-03-27
Marketing CategoryANDA / ANDA
Application NumberANDA076667
Labeler NameTarget Brands Inc.
Substance NameFEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
Active Ingredient Strength60 mg/1; mg/1
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 11673-032-14

4 BLISTER PACK in 1 CARTON (11673-032-14) > 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
Marketing Start Date2015-03-27
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 11673-032-14 [11673003214]

Fexofenadine HCl and Pseudoephedrine HCI TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA076667
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-03-27
Marketing End Date2016-02-02

Drug Details

Active Ingredients

IngredientStrength
FEXOFENADINE HYDROCHLORIDE60 mg/1

OpenFDA Data

SPL SET ID:235d29cf-5d75-1232-900f-cf8a4b22d055
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 997406
  • NDC Crossover Matching brand name "Fexofenadine HCl and Pseudoephedrine HCI" or generic name "Fexofenadine Hcl And Pseudoephedrine Hci"

    NDCBrand NameGeneric Name
    0363-0448Fexofenadine HCl and Pseudoephedrine HCIFexofenadine HCl and Pseudoephedrine HCI
    0363-1606Fexofenadine HCl and Pseudoephedrine HCIFexofenadine HCl and Pseudoephedrine HCI
    0536-1242Fexofenadine HCl and Pseudoephedrine HCIFexofenadine HCl and Pseudoephedrine HCI
    11673-032Fexofenadine HCl and Pseudoephedrine HCIFexofenadine HCl and Pseudoephedrine HCI
    21130-557Fexofenadine HCl and Pseudoephedrine HCIFexofenadine HCl and Pseudoephedrine HCI
    30142-447Fexofenadine HCl and Pseudoephedrine HCIFexofenadine HCl and Pseudoephedrine HCI
    30142-611Fexofenadine HCl and Pseudoephedrine HCIFexofenadine HCl and Pseudoephedrine HCI
    37808-022Fexofenadine HCl and Pseudoephedrine HCIFexofenadine HCl and Pseudoephedrine HCI
    43598-823Fexofenadine HCl and Pseudoephedrine HCIFexofenadine HCl and Pseudoephedrine HCI
    49035-273Fexofenadine HCl and Pseudoephedrine HCIFexofenadine HCl and Pseudoephedrine HCI
    55111-447Fexofenadine HCl and Pseudoephedrine HCIFexofenadine HCl and Pseudoephedrine HCI
    55111-557Fexofenadine HCl and Pseudoephedrine HCIFexofenadine HCl and Pseudoephedrine HCI
    59779-508Fexofenadine HCl and Pseudoephedrine HCIFexofenadine HCl and Pseudoephedrine HCI
    69842-249Fexofenadine HCl and Pseudoephedrine HCIFexofenadine HCl and Pseudoephedrine HCI
    70000-051812HR Allergy and Congestion ReliefFexofenadine HCl and Pseudoephedrine HCI
    11822-7388Allergy and CongestionFexofenadine HCl and Pseudoephedrine HCI
    62011-0455Allergy and CongestionFexofenadine HCl and Pseudoephedrine HCI

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.